- Home
- ONFO vs GTBP Comparison
ONFO vs GTBP Comparison
Compare ONFO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- GTBP
- Stock Information
- Founded
- ONFO 2018
- GTBP 1965
- Country
- ONFO United States
- GTBP United States
- Employees
- ONFO N/A
- GTBP N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- ONFO Technology
- GTBP Health Care
- Exchange
- ONFO Nasdaq
- GTBP Nasdaq
- Market Cap
- ONFO 5.2M
- GTBP 5.5M
- IPO Year
- ONFO 2022
- GTBP N/A
- Fundamental
- Price
- ONFO $1.02
- GTBP $0.95
- Analyst Decision
- ONFO
- GTBP Strong Buy
- Analyst Count
- ONFO 0
- GTBP 1
- Target Price
- ONFO N/A
- GTBP $11.00
- AVG Volume (30 Days)
- ONFO 26.1K
- GTBP 292.5K
- Earning Date
- ONFO 08-14-2025
- GTBP 08-14-2025
- Dividend Yield
- ONFO N/A
- GTBP N/A
- EPS Growth
- ONFO N/A
- GTBP N/A
- EPS
- ONFO N/A
- GTBP N/A
- Revenue
- ONFO $10,508,728.00
- GTBP N/A
- Revenue This Year
- ONFO N/A
- GTBP N/A
- Revenue Next Year
- ONFO N/A
- GTBP N/A
- P/E Ratio
- ONFO N/A
- GTBP N/A
- Revenue Growth
- ONFO 78.36
- GTBP N/A
- 52 Week Low
- ONFO $0.61
- GTBP $0.88
- 52 Week High
- ONFO $1.88
- GTBP $4.10
- Technical
- Relative Strength Index (RSI)
- ONFO 46.27
- GTBP 26.68
- Support Level
- ONFO $0.93
- GTBP $0.88
- Resistance Level
- ONFO $1.03
- GTBP $0.99
- Average True Range (ATR)
- ONFO 0.06
- GTBP 0.10
- MACD
- ONFO -0.00
- GTBP 0.01
- Stochastic Oscillator
- ONFO 52.94
- GTBP 9.92
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.